These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11895934)

  • 1. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
    Bhushan R; Anthony BF; Frasch CE
    Infect Immun; 1998 Dec; 66(12):5848-53. PubMed ID: 9826364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo.
    Arjunaraja S; Paoletti LC; Snapper CM
    J Immunol; 2012 Jun; 188(11):5238-46. PubMed ID: 22523389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of antibodies to type III group B streptococcal polysaccharide.
    Guttormsen HK; Baker CJ; Edwards MS; Paoletti LC; Kasper DL
    J Infect Dis; 1996 Jan; 173(1):142-50. PubMed ID: 8537651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.
    Edwards MS; Lane HJ; Hillier SL; Rench MA; Baker CJ
    Vaccine; 2012 Jun; 30(28):4123-6. PubMed ID: 22537994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine.
    Baker CJ; Rench MA; McInnes P
    Vaccine; 2003 Jul; 21(24):3468-72. PubMed ID: 12850362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
    Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
    Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
    Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
    Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
    Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
    Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
    Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Edwards MS; Kasper DL
    J Infect Dis; 2004 Mar; 189(6):1103-12. PubMed ID: 14999615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
    Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.
    Baker CJ; Rench MA; Fernandez M; Paoletti LC; Kasper DL; Edwards MS
    J Infect Dis; 2003 Jul; 188(1):66-73. PubMed ID: 12825173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.
    Kotloff KL; Fattom A; Basham L; Hawwari A; Harkonen S; Edelman R
    Vaccine; 1996 Apr; 14(5):446-50. PubMed ID: 8735558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Multiplex Immunoassays for Quantification of IgG against Group B
    Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.
    Wessels MR; Paoletti LC; Rodewald AK; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1993 Nov; 61(11):4760-6. PubMed ID: 8406875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.